The main valvular heart diseases (VHDs), rheumatic heart diseases affect around 41 million people worldwide. VHDs can reduce the quality of life, physical functionality and sometimes cause sudden death.
In medical field, the evolution of new technologies is opening up new horizons, presenting innovative solutions that are increasingly closer to the needs of the patient.